Author:
Sun Xiaohang,Nomoto Takahiro,Takemoto Hiroyasu,Matsui Makoto,Guo Haochen,Sun Yudi,Miura Yutaka,Nishiyama Nobuhiro
Funder
Japan Agency for Medical Research and Development
Ministry of Education, Culture, Sports, Science and Technology
Japan Science and Technology Agency
Japan Society for the Promotion of Science
Reference36 articles.
1. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura;Cancer Res.,1986
2. Tumoritropic and lymphotropic principles of macromolecular drugs;Maeda;Crit. Rev. Ther. Drug Carrier Syst.,1989
3. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology;Prabhakar;Cancer Res.,2013
4. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity;Maeda;Adv. Drug Deliv. Rev.,2015
5. EPR: evidence and fallacy;Nichols;J. Control. Release,2014
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献